These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11378641)

  • 21. Detection of HCV salivary antibodies by a simple and rapid test.
    Yaari A; Tovbin D; Zlotnick M; Mostoslavsky M; Shemer-Avni Y; Hanuka N; Burbea Z; Katzir Z; Storch S; Margalith M
    J Virol Methods; 2006 Apr; 133(1):1-5. PubMed ID: 16360219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of hepatitis C virus (HCV) RNA and anti-HCV results and evaluation of the relationship between transaminase levels].
    Kaşifoğlu N; Us T; Akgün Y
    Mikrobiyol Bul; 2007 Oct; 41(4):557-63. PubMed ID: 18173074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged hepatitis C virus seroconversion in a blood donor, detected by HCV antigen test in parallel with HCV RNA.
    Alvarez M; Planelles D; Vila E; Montoro J; Franco E
    Vox Sang; 2004 May; 86(4):266-7. PubMed ID: 15144533
    [No Abstract]   [Full Text] [Related]  

  • 24. The hepatitis C virus genotype and subtype frequency in hepatitis C virus RNA-positive, hepatitis C virus antibody-negative blood donors identified in the nucleic acid test screening program in Poland.
    Brojer E; Gronowska A; Medyńska J; Grabarczyk P; Mikulska M; Letowska M; Kryczka W; Gietka A
    Transfusion; 2004 Dec; 44(12):1706-10. PubMed ID: 15584984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C viral infection is not associated with Waldenström's macroglobulinemia.
    Leleu X; O'Connor K; Ho AW; Santos DD; Manning R; Xu L; Hatjiharissi E; Moreau AS; Branagan AR; Hunter ZR; Dimmock EA; Soumerai J; Patterson C; Ghobrial I; Treon SP
    Am J Hematol; 2007 Jan; 82(1):83-4. PubMed ID: 16955461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Low positive anti-HCV microparticle enzyme immunoassay results: do they predict hepatitis C virus infection?].
    Sayan M; Meriç M; Mutlu B; Celebi S; Willke A
    Mikrobiyol Bul; 2006; 40(1-2):81-4. PubMed ID: 16775961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection.
    Ansaldi F; Bruzzone B; Testino G; Bassetti M; Gasparini R; Crovari P; Icardi G
    J Viral Hepat; 2006 Jan; 13(1):5-10. PubMed ID: 16364076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
    Said ZN; El-Sayed MH; El-Bishbishi IA; El-Fouhil DF; Abdel-Rheem SE; El-Abedin MZ; Salama II
    Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between salivary anti-HCV antibodies and HCV RNA in saliva and salivary glands of patients with chronic hepatitis C.
    Caldeira PC; Oliveira e Silva KR; Silva TA; de Mattos Camargo Grossmann S; Teixeira R; Carmo MA
    J Oral Pathol Med; 2013 Mar; 42(3):222-8. PubMed ID: 22924776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and clinical role of GBV-C infection after cardiac surgery in childhood: a study on 414 patients.
    Vogt M; Klostermann B; Braun S; Busch R; Hess J; Frösner G; Lang T
    J Infect; 2006 Jul; 53(1):43-8. PubMed ID: 16253334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
    Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y
    Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural history of acute symptomatic hepatitis type C.
    Wawrzynowicz-Syczewska M; Kubicka J; Lewandowski Z; Boroń-Kaczmarska A; Radkowski M
    Infection; 2004 Jun; 32(3):138-43. PubMed ID: 15188072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
    Ahmad N; Asgher M; Shafique M; Qureshi JA
    Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
    Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
    J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occult hepatitis B virus and hepatitis C virus infections.
    Carreño V; Bartolomé J; Castillo I; Quiroga JA
    Rev Med Virol; 2008; 18(3):139-57. PubMed ID: 18265423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy of hepatitis C virus core antigen testing in pools among seroconverters.
    Beer N; Shinar E; Novack L; Safi J; Soliman H; Yaari A; Goldman-Levi R; Yahalom V; Bolotin A; Sarov B
    Transfusion; 2006 Oct; 46(10):1822-8. PubMed ID: 17002640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis.
    Watkins-Riedel T; Ferenci P; Steindl-Munda P; Gschwantler M; Mueller C; Woegerbauer M
    Clin Infect Dis; 2004 Dec; 39(12):1754-60. PubMed ID: 15578395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.